Pod1um-304: Phase Iii Study of Retifanlimab Plus Platinum-Based Chemotherapy (Chemo) as First-Line (1l) Therapy for Nonsquamous or Squamous Metastatic Nonesmall Cell Lung Cancer (Mnsclc)
| dc.contributor.author | Lu, S. | |
| dc.contributor.author | Vynnychenko, O. | |
| dc.contributor.author | Kulyaba, Y. | |
| dc.contributor.author | Kuchava, V. | |
| dc.contributor.author | Ibrahim, A. | |
| dc.contributor.author | Moiseenko, F. V. | |
| dc.contributor.author | Bondarenko, I. | |
| dc.date.accessioned | 2025-04-25T19:49:49Z | |
| dc.date.available | 2025-04-25T19:49:49Z | |
| dc.date.issued | 2024 | |
| dc.description | Bondarenko, Igor/0000-0002-7071-2471 | en_US |
| dc.description.sponsorship | Incyte Corporation, Wilmington, DE, USA | en_US |
| dc.description.sponsorship | Incyte Corporation, Wilmington, DE, USA. | en_US |
| dc.identifier.doi | 10.1016/j.annonc.2024.10.660 | |
| dc.identifier.issn | 0923-7534 | |
| dc.identifier.issn | 1569-8041 | |
| dc.identifier.uri | https://doi.org/10.1016/j.annonc.2024.10.660 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14365/6055 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.relation.ispartof | European-Society-for-Medical-Oncology Asia Congress (ESMO) -- DEC 06-08, 2024 -- Singapore, SINGAPORE | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Pod1um-304: Phase Iii Study of Retifanlimab Plus Platinum-Based Chemotherapy (Chemo) as First-Line (1l) Therapy for Nonsquamous or Squamous Metastatic Nonesmall Cell Lung Cancer (Mnsclc) | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication | |
| gdc.author.id | Bondarenko, Igor/0000-0002-7071-2471 | |
| gdc.author.wosid | Bondarenko, Igor/U-5156-2017 | |
| gdc.bip.impulseclass | C5 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C5 | |
| gdc.coar.access | metadata only access | |
| gdc.coar.type | text::conference output | |
| gdc.collaboration.industrial | true | |
| gdc.description.department | İzmir Ekonomi Üniversitesi | en_US |
| gdc.description.departmenttemp | [Lu, S.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Chest Hosp, Dept Med Oncol, Shanghai, Peoples R China; [Vynnychenko, O.] Univ Hosp Sumy State Univ, Clin Oncol, Sumy, Ukraine; [Kulyaba, Y.] Asklepion LLC, Oncol Dept, Med Ctr, Kyiv, Ukraine; [Kuchava, V.] Inst Clin Oncol LTD, Oncol, Tbilisi, Georgia; [Ibrahim, A.] Hosp Tengku Ampuan Afzan Kuantan, Resp Clin, Kuantan, Malaysia; [Moiseenko, F. V.] FSBI CRPC Specialized Med Care Oncol, Chemotherapy Dept, St Petersburg, Russia; [Arslan, C.] Izmir Econ Univ, Med Point Hosp, Med Oncol Dept, Izmir, Turkiye; [Nguyen, D. T.] Natl Lung Hosp, Dept Med Oncol, Hanoi, Vietnam; [Zhang, M.] Anhui Med Univ, Hosp 2, Dept Oncol, Hefei, Peoples R China; [Petrovic, M. D.] Clin Ctr Kragujevac, Pulm Dept, Kragujevac, Serbia; [Cicin, I.] Istinye Univ Med Oncol, Dept Med Oncol, Istanbul, Turkiye; [Cicin, I.] IAU VM Med Pk Florya Hosp, Istanbul, Turkiye; [Bibichadze, K.] JSC EVEX Hosp, Dept Oncol, Tbilisi, Georgia; [Cil, T.] Adana City Educ & Res Hosp, Dept Med Oncol, Adana, Turkiye; [Cornfeld, M.] Incyte Corp, Immunooncol Dept, Wilmington, DE USA; [Tian, C.] Incyte Corp, Biostat, Wilmington, DE USA; [Munteanu, M.] Incyte, Oncol Clin Res Dept, Wilmington, DE USA; [Sette, C. V. D. M.] Ctr Estudos & Pesquisas HO, Med Oncol, Santo Andre, SP, Brazil; [Bondarenko, I.] Dnipropetrovsk State Med Acad, Oncol & Med Radiol Dept, Dnipro, Ukraine | en_US |
| gdc.description.endpage | S1634 | en_US |
| gdc.description.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q1 | |
| gdc.description.startpage | S1633 | en_US |
| gdc.description.volume | 35 | en_US |
| gdc.description.woscitationindex | Science Citation Index Expanded - Conference Proceedings Citation Index - Science | |
| gdc.description.wosquality | Q1 | |
| gdc.identifier.openalex | W4405165519 | |
| gdc.identifier.wos | WOS:001401985200416 | |
| gdc.index.type | WoS | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 0.0 | |
| gdc.oaire.influence | 2.4895952E-9 | |
| gdc.oaire.isgreen | false | |
| gdc.oaire.popularity | 2.3737945E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.openalex.collaboration | International | |
| gdc.openalex.fwci | 0.0 | |
| gdc.openalex.normalizedpercentile | 0.42 | |
| gdc.opencitations.count | 0 | |
| gdc.plumx.mendeley | 1 | |
| gdc.wos.citedcount | 0 | |
| relation.isOrgUnitOfPublication | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 |